文献速递淋巴瘤

晚期霍奇金淋巴瘤国际预后指数:HoLISTIC联盟临床预测模型的开发与验证

The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium.
PubMed 文献 · J Clin Oncol · 2022-12-10

基于8项国际III期临床试验4022例新诊断晚期成人经典型霍奇金淋巴瘤患者开发临床预测模型,并在4个真实世界注册研究1431例 contemporaneously 治疗患者中外部验证。模型纳入年龄、性别、分期、巨块、绝对淋巴细胞计数、血红蛋白和白蛋白,年龄与绝对淋巴细胞计数呈非线性关系。与IPS相比,模型对OS的区分度更优,对PFS和OS的校准更佳。

要点

  • 模型开发队列中位年龄33岁(范围18-65岁),结节硬化型为最常见组织学亚型。
  • 开发队列5年PFS的Kaplan-Meier估计值为0.77,5年OS为0.92。
  • 模型对5年PFS和OS的乐观校正c统计量分别为0.590和0.720。

核心结论

  • 在超过5000例晚期经典型霍奇金淋巴瘤患者中严格开发并外部验证了临床预测模型,识别了若干新的非线性关系并改善了患者结局预测。
  • 与IPS相比,模型对OS的区分度更优,对PFS和OS的校准更佳。
  • 已创建在线计算器供个体化床旁使用。

研究设计与样本

  • 模型开发遵循多变量预测模型个体预后或诊断透明报告指南,基于1996年至2014年开展的8项国际III期临床试验中4022例新诊断晚期成人经典型霍奇金淋巴瘤患者。
  • 外部验证基于4个真实世界经典型霍奇金淋巴瘤注册研究中1431例 contemporaneously 治疗患者。
  • 采用分段线性样条评估连续变量的潜在非线性关系,使用Cox比例风险模型估计5年无进展生存期和总生存期。

主要发现

  • 开发队列中位年龄33岁(范围18-65岁),结节硬化型为最常见组织学亚型。
  • 开发队列5年PFS的Kaplan-Meier估计值为0.77,5年OS为0.92。
  • 显著预测变量包括年龄、性别、分期、巨块、绝对淋巴细胞计数、血红蛋白和白蛋白,PFS与OS间略有差异。
  • 年龄和绝对淋巴细胞计数与结局呈非线性关系。
  • 开发模型对5年PFS和OS的乐观校正c统计量分别为0.590和0.720。

临床怎么用

  • 已创建在线计算器供个体化床旁使用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The International Prognostic Score (IPS) has been used in classic Hodgkin lymphoma (cHL) for 25 years. However, analyses have documented suboptimal performance of the IPS among contemporarily treated patients. Harnessing multisource individual patient data from the Hodgkin Lymphoma International Study for Individual Care consortium, we developed and validated a modern clinical prediction model. METHODS: Model development via Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis guidelines was performed on 4,022 patients with newly diagnosed advanced-stage adult cHL from eight international phase III clinical trials, conducted from 1996 to 2014. External validation was performed on 1,431 contemporaneously treated patients from four real-world cHL registries. To consider association over a full range of continuous variables, we evaluated piecewise linear splines for potential nonlinear relationships. Five-year progression-free survival (PFS) and overall survival (OS) were estimated using Cox proportional hazard models. RESULTS: The median age in the development cohort was 33 (18-65) years; nodular sclerosis was the most common histology. Kaplan-Meier estimators were 0.77 for 5-year PFS and 0.92 for 5-year OS. Significant predictor variables included age, sex, stage, bulk, absolute lymphocyte count, hemoglobin, and albumin, with slight variation for PFS versus OS. Moreover, age and absolute lymphocyte count yielded nonlinear relationships with outcomes. Optimism-corrected c-statistics in the development model for 5-year PFS and OS were 0.590 and 0.720, respectively. There was good discrimination and calibration in external validation and consistent performance in internal-external validation. Compared with the IPS, there was superior discrimination for OS and enhanced calibration for PFS and OS. CONCLUSION: We rigorously developed and externally validated a clinical prediction model in > 5,000 patients with advanced-stage cHL. Furthermore, we identified several novel nonlinear relationships and improved the prediction of patient outcomes. An online calculator was created for individualized point-of-care use.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Rodday AM, Parsons SK, Upshaw JN, et al. The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium. J Clin Oncol. 2022. PMID: 36495588. doi:10.1200/JCO.22.02473

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。